Katy Shaw-Saliba

Initiator
DISC Type : Di

Vice President at Infinity Bio, Inc.

Baltimore, Maryland, United States

Overview

Katy Shaw-Saliba is the VP of Scientific Development at Infinity Bio, Inc. , a seasoned executive with deep expertise in clinical research, laboratory science, and R&D pipelines. With a PhD from Johns Hopkins, she specializes in translating complex data into high-impact scientific communications and strategy, with a focus on antibody response.

She is passionate about human health and fostering global scientific relationships, demonstrated by her collaborative clinical research in West and Central Africa. Katy values her connections with international colleagues, such as her team in Mali, viewing them as lifelong partners in advancing science and health.

Unique fact: While at the NIAID, she directed multi-million dollar global clinical research studies, including a $3. 3M measles vaccine initiative and trials for Ebola virus countermeasures.

Personality Overview

Conviction Driven

Impact-Oriented

Confident

They respond well to objective pitches but also attach some value to relationships.  They usually prefer to drive the conversation. They don’t mind taking a stand if they believe in something.

Topics They Care About

Antibody Reactome
Her work at Infinity Bio, Inc. is centered on the company's proprietary antibody reactome profiling platform, which she frequently discusses in webinars and company announcements.
Global Clinical Research
Directed multi-million dollar, international clinical studies for the NIAID in West and Central Africa, focusing on high-consequence pathogens like Ebola.
Infectious Disease
Has an extensive publication record on topics including SARS-CoV-2, Influenza, and MPXV, and received a NIAID Merit Award for her work on COVID-19 biomarkers.

Media Appearances

Katy has no verified media appearances

Work History

9-2025
Vice President at Infinity Bio, Inc.
5-2025 - 9-2025
Director, Scientific Development at Infinity Bio, Inc.
8-2020 - 4-2025
Supervisory Health Scientist & Laboratory Lead at National Institute of Allergy and Infectious Diseases (NIAID)
2-2018 - 8-2020
Faculty at The Johns Hopkins University School of Medicine
2-2018 - 8-2020
Executive Director at The Johns Hopkins Center of Excellence for Influenza Research and Surveillance

Education

2013 - 2016
Postdoctoral Research Fellow from Harvard T.H. Chan School of Public Health
2008 - 2012
PhD from Johns Hopkins Bloomberg School of Public Health

More Information

Social Presence :

Prographics :

Exp : 9 Location : Baltimore, Maryland, United States Job Level : Senior Designation : Vice President at Infinity Bio, Inc.
URL has been copied!

Insights For Selling To Katy

During A Call Or A Meeting

DO's

  • Get them to a point where they are ready to bat for your product internally
  • Focus on the big picture and the strategic value of your product
  • Clearly address the competitive aspects

DONT's

  • Don’t keep repeating the same information, it could make them impatient
  • Don’t be too verbose or overly friendly; a little bit, however, is fine
  • Don’t be very informal even if they are being so themselves

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Katy is

  • Confidence in the product’s value is critical, followed by relationship and a sense of achievement.
  • Will you ever get a clear answer from Katy

  • They will not hesitate to say no if they do not develop conviction.

Insights For Deal Planning

    How fast (or slow) will Katy move?

  • They can take fast decisions if they develop conviction in the product and find you trustworthy.
  • Can Katy take some risk or not?

  • They have the capability of taking risky decisions if necessary.

You And Katy

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.